NASDAQ:LXRX
Lexicon Pharmaceuticals, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.lexpharma.comipo date
Apr 07, 2000
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus